Home - Anagin :: Anagin

The Right to Live Fearlessly

First-in-Class Therapies

Anagin’s research offers hope of a future without fear or pain for millions of patients worldwide suffering from a variety of neuropsychiatric disorders.
The Story Behind Anagin

Mission First-in-Class Research

Anagin is developing first-in-class novel targeted therapies for addressing pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. Such diseases include, but are not limited to, Post Traumatic Stress Disorder (PTSD), Traumatic Brain Injury (TBI), Depression, Neuropathic Pain, Alzheimer’s disease and Parkinson’s disease.

Research and Development

The Anagin Difference

In the Press

Inching Toward a Cure
In the Press

PTSD At the Crossroads
In the Press

Indiana Life Sciences Leaders Broaden Focus to People

The Right to Live Fearlessly

First-in-Class Therapies

Mission First-in-Class Research

Inching Toward a Cure

PTSD At the Crossroads

Indiana Life Sciences Leaders Broaden Focus to People